Medicilon introduces Bio-Plex suspension chip multiple detection platform

The Bio-Plex suspension chip multiple detection platform can simultaneously detect up to 100 molecules in the same sample. Because of its good data reproducibility, it is now widely used in immunology and various disease research. Such as cardiovascular disease, tumor-specific biomarker screening, drug treatment target development, drug treatment effect evaluation, disease-related angiogenesis, metastasis, cell proliferation, apoptosis, inflammation, signal transduction, and cytokine release in cell therapy Disease monitoring research, etc. The Bio-Plex system can simultaneously detect multiple target proteins such as interleukins, interferons and other cytokines, growth factors, chemokines, inflammatory factors, apolipoproteins, phosphorylated proteins, and disease-specific markers such as diabetes and cancer. , And screen out the main relevant biomarker or drug target from it, to determine the direction for follow-up research and application.

Advantages of Bio-Plex Suspension Chip Multiple Detection Platform

Unique system calibration and verification tools for internal quality control to ensure the accuracy, reproducibility and comparability of experimental data

Advanced weighted 5-parameter mathematical statistics technology to ensure the reliability and accuracy of data

Powerful operating software, man-machine dialogue operation, easy to learn

Open xMAP technology platform, compatible with all Multi-Plex detection including nucleic acid

Comprehensive detection reagents for cytokines, phosphorylated proteins, diabetes, angiogenesis, acute phase, etc. various molecular and cell biology and disease research

Take the lead in introducing magnetic bead detection technology, making the operation faster and easier

The Bio-Plex suspension chip multiple detection platform is developed based on the flexible xMAP technology. With the help of microsphere array technology and flow cytometry technology, it can simultaneously quantify a variety of biomolecules (proteins, peptides and nucleic acid fragments) in trace samples. , To quickly achieve simultaneous screening of multiple Biomarkers. Medicilon’s introduction of the Bio-Plex suspension chip multiple detection platform will greatly improve the efficiency of scientific research and innovation, and at the same time improve the quality of in vitro biology services.

The Biology Department of Medicilon has rich and extensive experience in the field of in vitro biology. Medicilon uses enzyme level determination, cell level determination, cell biology, biochemistry, in vitro isotope determination, stable cell line establishment, gene knockout, RNAi And MicroRNA technology, etc., can provide a complete set of biological services.

Medicilon’s in vitro biology project:

In vitro biochemical analysis

Verify physical and chemical testing

Cell level analysis

Western blot analysis

Migration assay of HT1080 cells and MDA-MB-231 cells

Radioisotope analysis